Source:http://linkedlifedata.com/resource/pubmed/id/10096549
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1999-4-13
|
pubmed:abstractText |
Germ-line mutations of the human TSC2 tumor suppressor gene cause tuberous sclerosis (TSC), a disease characterized by the development of hamartomas in various organs. In the Eker rat, however, a germ-line Tsc2 mutation gives rise to renal cell carcinomas with a complete penetrance. The molecular mechanism for this phenotypic difference between man and rat is currently unknown, and the physiological function of the TSC2/Tsc2 product (tuberin) is not fully understood. To investigate these unsolved problems, we have generated a Tsc2 mutant mouse. Tsc2 heterozygous mutant (Tsc2+/-) mice developed renal carcinomas with a complete penetrance, as seen in the Eker rat, but not the angiomyolipomas characteristic of human TSC, confirming the existence of a species-specific mechanism of tumorigenesis caused by tuberin deficiency. Unexpectedly, approximately 80% of Tsc2+/- mice also developed hepatic hemangiomas that are not observed in either TSC or the Eker rat. Tsc2 homozygous (Tsc2-/-) mutants died around embryonic day 10.5, indicating an essential function for tuberin in mouse embryonic development. Some Tsc2-/- embryos exhibited an unclosed neural tube and/or thickened myocardium. The latter is associated with increased cell density that may be a reflection of loss of a growth-suppressive function of tuberin. The mouse strain described here should provide a valuable experimental model to analyze the function of tuberin and its association with tumorigenesis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1206-11
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10096549-Animals,
pubmed-meshheading:10096549-Carcinoma, Renal Cell,
pubmed-meshheading:10096549-Embryonic and Fetal Development,
pubmed-meshheading:10096549-Genes, Tumor Suppressor,
pubmed-meshheading:10096549-Germ-Line Mutation,
pubmed-meshheading:10096549-Hemangioma,
pubmed-meshheading:10096549-Heterozygote,
pubmed-meshheading:10096549-Homozygote,
pubmed-meshheading:10096549-Humans,
pubmed-meshheading:10096549-Kidney Neoplasms,
pubmed-meshheading:10096549-Liver Neoplasms,
pubmed-meshheading:10096549-Mice,
pubmed-meshheading:10096549-Mice, Knockout,
pubmed-meshheading:10096549-Mice, Mutant Strains,
pubmed-meshheading:10096549-Rats,
pubmed-meshheading:10096549-Repressor Proteins,
pubmed-meshheading:10096549-Tumor Suppressor Proteins
|
pubmed:year |
1999
|
pubmed:articleTitle |
Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice.
|
pubmed:affiliation |
Department of Experimental Pathology, Cancer Institute, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|